Adam Margolis spent 20 years flying without a net in a business devoted to building nets. L&M Healthcare Communications organized speaker programs in a regulated industry, where a missed contract, an incomplete record or a sloppy transfer-of-value report could turn a smooth event into an expensive headache. Its work depended on systems, checks and people who noticed the detail everyone else hoped somebody had noticed. The founder's preferred description of independent ownership is therefore perfect: vivid, slightly comic and only half true.
The company Margolis built with Lenny LaManna began in 2005 as a specialist medical education agency. Margolis brought the commercial and operating experience. LaManna, a podiatric surgeon, brought clinical and medical strategy. They were selling neither medicine nor media in the usual sense. Their product was the difficult middle: helping life-sciences companies turn complex information into credible education for healthcare professionals, then making the speakers, materials, venues, technology and reporting behave as one program.
By then, Margolis had already spent years in medical education and communications at firms around the New York tri-state region. He had attended Columbia University from 1989 to 1993, then entered a field that sits close to advertising but lives by a different clock. Consumer campaigns can sometimes survive on a brilliant impression. Medical communications has to remain accurate through revision, approval, training and delivery. The work rewards stamina and institutional memory. Margolis eventually described himself as a 30-year pharmaceutical marketing and communications veteran, but the more telling credential was the company he kept improving long after its founding story had ceased to be new.
In 2006, with the agency still new enough to require an introduction, Margolis put its thesis plainly: “Medical education is one of the most important aspects of the pharmaceutical marketing mix.” He argued that education had to be targeted and credible if it was going to matter during a product launch. The language belongs to its era; the operating problem has survived every change of channel since.
The operating thesisThe glamour was in getting the details right
Speaker bureaus are easy to underestimate. A clinician speaks to other clinicians. People listen. Dinner may be served. Yet behind that ordinary scene sits a small republic of obligations: identifying and training faculty, customizing content, contracting, scheduling, managing fair-market-value payments, recording attendance, auditing programs and producing compliance reports. A single event touches strategy, science, hospitality, finance, law and software. The audience should never feel the machinery. The operator has to feel all of it.
Margolis made that machinery part of the pitch. L&M built its organization around speaker bureau management, technology, customer service and compliance. He stayed close to clients and kept what the company described as an open-door approach to satisfaction and technological development. “Adaptability and experience are the cornerstones of great medical education,” he said during an early expansion of the firm. It sounds like a service-business maxim because it is one. The surprise is how much software eventually sat beneath it.
One educational event, five linked jobs
The platform was called STARS, short for Speaker Tracking and Reporting System. L&M developed it continuously for two decades. Margolis remembers the earliest version as software that looked quite different from what it became: a cloud-based, end-to-end platform for planning events, managing contracts, tracking compliance and producing the records required when value passes to a healthcare professional. Its history is less a flash of invention than the patient accumulation of edge cases. A product gets useful one awkward client request at a time.
“Form follows function.”Adam Margolis on letting client strategy determine the program format
The room changesA game show, a 3D studio and the problem of attention
The test arrived abruptly in March 2020. Live educational programs moved to screens, and a field accustomed to hotels and meeting rooms had to learn the peculiar physics of the muted microphone. Margolis did not treat virtual delivery as a temporary imitation of the real thing. He argued for a lasting mix of live, virtual and hybrid programs, chosen for the people and purpose involved.
His suggestions were refreshingly unsolemn. Use polling. Quiz the room. Borrow the mechanics of Jeopardy! or Hollywood Squares. Build a 3D studio for a regional broadcast. The point was not to decorate data but to signal respect for the audience's time. Clinicians had endured enough windows filled with slides. A useful program had to make participation feel like participation.
This is the recurring Margolis instinct: content and logistics are not rival disciplines. Credibility is weakened if the technology sputters, if the format ignores the room or if the compliance trail becomes an afterthought. He calls the approach 360 degrees. Less elegantly, it means nothing gets to plead that it belongs to somebody else's department.
The long exitSix months at the table, years in preparation
After two decades, Margolis and LaManna decided the company had reached the right combination of clients, employees and capabilities to test the market. From the first conversations with bankers to closing, the formal process took a little more than six months. That tidy number conceals the more useful one: years.
In a 2026 conversation about the sale, Margolis returned to decisions made well before a buyer appeared. Hiring a part-time chief financial officer was among the most important. Better reporting gave the owners visibility into the business and made the company easier to understand under scrutiny. Clean accounts are dull until dozens of strangers begin asking questions about them. Then dullness becomes a luxury.
The founders chose an investment banker, narrowed a field of buyers and endured diligence, that peculiar corporate ritual in which success is rewarded with requests for more spreadsheets. Yet price was not the only filter. Margolis cared about continuity, culture and the fate of employees. He and LaManna were not interested in private-equity funding by itself. They wanted an operating home where L&M's peer-to-peer specialization could connect to more of the product lifecycle.
The choice reveals a useful difference between selling out and selling onward. A purely financial transaction could have rewarded the owners while leaving the operating logic of L&M stranded. Integration offered a chance to preserve that logic and extend it. The agency's expertise could enter earlier conversations about naming and medical affairs, then remain present through market access, commercialization and the live programs where strategy finally meets an audience. For Margolis, the appeal was continuity with added range. He could hand over ownership without pretending the company had finished becoming itself.
Fingerpaint Group supplied that larger home. Its November 2025 acquisition placed L&M inside Fingerpaint Medical, alongside strategy, medical affairs, branding, market access and broader commercialization services. The terms were not disclosed. The L&M leadership team stayed. STARS came too.
“We really wanted to integrate with a great team to bring our service to a bigger firm.”Adam Margolis on choosing the next owner
After ownershipThe second act is still an operating job
A founder can sell a business faster than he can stop being its founder. Margolis went from owner and chief executive to managing director. The shift carries an emotional arithmetic no spreadsheet captures: less sovereignty, more reach; fewer final calls, more colleagues; an institution once bounded by the founders now inserted into a larger one.
He has framed the change around what it gives the team. Employees gain resources, broader career paths and access to more specialties. Clients keep familiar people while gaining services upstream and downstream of the speaker program. STARS moves from a specialist agency's infrastructure into a larger medical communications system. Margolis has also pointed toward AI-assisted streamlining and new approaches to data management, aspirations that make sense for a platform whose advantage has always been accumulated operational memory.
The partnership that started L&M remains essential to the story. Margolis and LaManna paired different forms of authority: one commercial and operational, the other clinical and strategic. Their firm lasted through changes in regulation, technology, channels and client expectations because the combination matched the work. When the founders finally picked a buyer, they again chose combination over purity.
Margolis's career does not offer the usual founder mythology. There is no dorm-room epiphany, consumer craze or overnight rocket. There is a long table covered in contracts, schedules and revisions. There are hundreds of tiny assurances that a complicated program will run as promised. There is software improved for 20 years. There is a sale prepared before it was urgent.
That makes his story more useful, not less. Most durable companies are built in the middle, where expertise meets administration and where a client's trust depends on the next ordinary thing going right. Margolis spent two decades making those ordinary things compound. Then, at the moment when independence could have become an identity rather than a strategy, he traded the netless flight for a bigger aircraft. He did not leave the cockpit. He simply accepted that there would be more hands on the controls.